A Rare Parathyroid Carcinoma in Young Adult Man: Therapeutic Challenges in Tertiary Hospital with its Limitations

Rupita Sari Endangena Sitanggang, Yohana Azhar, Hasrayati Agustina


Introduction: Parathyroid carcinoma is a rare malignant neoplasm. The symptoms that arise are related to hyperparathyroid conditions, which are clinically difficult to distinguish between benign and malignant disorders. These conditions make the diagnosis and treatment of parathyroid carcinoma challenging.


Case Presentation: : In this case report, a 27-year-old male presented with weak limbs and a history of multiple recurrent fractures. Serum calcium ions and parathyroid hormone levels were increased. A comprehensive history taking, laboratory testing, and radiographic examination were used to confirm the diagnosis of parathyroid cancer. However, a histological study is still necessary to make a certain diagnosis. The patient underwent parathyroidectomy accompanied by intraoperative frozen section examination, then confirmed to have parathyroid carcinoma. Calcium serum evaluations were performed on the patient after surgery.


Conclusions: Parathyroid carcinoma is a very rare case. Clinical manifestations and the results of investigations that are not typical and rarely found together in one patient’s condition make the diagnosis of this case very difficult. Although recommendations or standard protocols in the management of parathyroid carcinoma do not yet exist, the results of case reports are expected to increase the knowledge and management of parathyroid carcinoma patients.


cancer, hyperparathyroid, parathyroid carcinoma,

Full Text: View | Download

DOI: 10.33371/ijoc.v18i1.1172

Article Metrics

Abstract View: 72,
PDF Download: 32


Oertli D, Udelsman R. Surgery of the thyroid and parathyroid glands: Springer; 2007.

Ullah A, Khan J, Waheed A, et al. Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives. Cancers (Basel). 2022 Mar 10;14(6):1426.

Mourinho Bala N, Aragüés JM, Guerra S, et al. Parathyroid Carcinoma: A Rare Endocrine Malignancy. Am J Case Rep. 2021 Dec 26;22:e934221.

Fernandes JMP, Paiva C, Correia R, et al. Parathyroid carcinoma: From a case report to a review of the literature. Int J Surg Case Rep. 2018;42:214-217.

Alperstein A, Bhayani R. Parathyroid carcinoma, a rare cause of primary hyperparathyroidism. BMJ Case Rep. 2014 Aug 19;2014:bcr2014204279.

Yasmin F, Rahman HA, Sharmin S, Uddin M. A Case Report on Parathyroid Carcinoma: A Diagnostic Dilemma. Bangladesh Journal of Nuclear Medicine. 2018;21(2):122-4.

de Almeida Vital JM, de Farias TP, Vaisman F, et al. Two case reports of parathyroid carcinoma and review of the literature. Journal of Oncological Sciences. 2017;3(1):22-8.

Clayman GL, Gonzalez HE, El‐Naggar A, Vassilopoulou‐Sellin R. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer. 2004 Mar 1;100(5):900-5.

Roser P, Leca BM, Coelho C, et al. Diagnosis and management of parathyroid carcinoma: a state-of-the-art review. Endocr Relat Cancer. 2023 Mar 22;30(4):e220287.

Wang O, Wang CY, Shi J, et al. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors. Chin Med J (Engl). 2012 Aug;125(16):2895-901.

Ikeda Cavamura ÉM, Miyake FK, Wiezel JY, et al. Case Report of Rare Parathyroid Tumor with Atypical Presentation and Early Diagnosis. Case Rep Endocrinol. 2022 Jan 11;2022:1675256.

Sturniolo G, Gagliano E, Tonante A, et al. Parathyroid carcinoma: case report. G Chir. 2013 May-Jun;34(5-6):170-2.

Fingeret AL. Contemporary Evaluation and Management of Parathyroid Carcinoma. JCO Oncol Pract. 2021 Jan;17(1):17-21. doi: 10.1200/JOP.19.00540.

McInerney NJ, Moran T, O'Duffy F. Parathyroid carcinoma: Current management and outcomes - A systematic review. Am J Otolaryngol. 2023 Jul-Aug;44(4):103843.


  • There are currently no refbacks.

Copyright (c) 2024 Rupita Sari Sitanggang

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.